A new RNA regulator emerges in the neuroimmune landscape of pain
A study published in *Brain* reveals a critical role for the long non-coding RNA *Carip* in modulating pain sensitivity through specific neuroimmune circuits. Researchers found *Carip* is highly expressed in the lateral parabrachial nucleus (LPBN), a brain region involved in pain processing. Thermal stimulation upregulated *Carip*, while its genetic knockout elevated pain thresholds in mice. Electrophysiological analysis showed that *Carip* deletion disrupted the excitation-inhibition (E/I) balance in LPBN neurons projecting to the central amygdala. This imbalance was driven by enhanced phosphorylation of synapsin1 via a protein kinase A (PKA) signaling cascade. Importantly, targeted knockdown of synapsin1 or PKA within this circuit restored neuronal balance and normalized pain behaviors, pinpointing *Carip* and its downstream effectors as a precise molecular axis for pain regulation.
Study Significance: This research identifies a novel lncRNA-mediated mechanism that directly controls neuronal E/I balance, a fundamental concept in neuroimmunology and synaptic physiology. For immunologists and neuroscientists, it underscores how non-coding genomic elements can orchestrate specific signaling pathways, like PKA, that intersect with immune-modulatory processes often implicated in chronic pain and inflammation. The findings suggest that targeting such RNA-driven intracellular cascades could inform next-generation strategies for immunotherapy in neuroinflammatory and chronic pain conditions, moving beyond traditional cytokine or receptor blockade.
Source →Stay curious. Stay informed — with Science Briefing.
Always double check the original article for accuracy.